NSE filing, NSE: DHTL. Summary written from the filing by ALFA Finder's alert engine.
Docmode Health Technologies Limited: key numbers
- Share price
- ₹22.05
- Market cap
- ₹6.93 Cr
- Revenue (annual)
- ₹25.52 Cr
- Net profit (annual)
- ₹-0.13 Cr
- P/E (TTM)
- -51.4×Sector 34.1×
- Promoter holding
- 29.50%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Docmode Health Technologies Limited
All →Docmode Health Technologies Other Announcement
Doctrack Solutions Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026. The report confirms a total issued capital of 31,42,800 equity shares.
Docmode Health Technologies Capital Structure Change
Ramesh Kumar Jain and Ramesh Jain HUF net acquired 20,000 DHTL shares on the open market, raising PAC stake to 11.45%. This SAST Reg 29(2) disclosure reflects a minor stake increase.
Docmode Health Technologies Annual General Meeting
Doctrack Solutions Limited conducted its 9th Annual General Meeting on September 30, 2026. Shareholders considered the adoption of audited financial statements and approved related party transactions.
Docmode Health Technologies Annual General Meeting
Docmode Health Technologies Limited issued the notice for its Annual General Meeting scheduled for September 30, 2026. The agenda includes financial statement adoption and RPT approval.
Docmode Health Technologies H2 FY26 Results: Net Loss of ₹0.1 Cr, Loss Narrows
Docmode Health Technologies Limited reported revenue from operations of ₹7.7 Cr (-64.0% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
- Key figure
- Net loss ₹0.1 Cr
Docmode Health Technologies Board Meeting Date
Doctrack Solutions Limited has rescheduled its board meeting to September 4, 2026. The board will consider and approve audited financial results for the half-year ended March 2026.
Other board meeting date announcements
All →Virat Industries Board Meeting Date
Brahm Virat Industries has scheduled a board meeting for November 5, 2026, to approve Q2 and H1 FY2027 results. Trading window closure began October 1, 2026.
Betex India Board Meeting Date
Betex India scheduled a board meeting for 4 Nov 2026 to approve un-audited Q1 and H1 FY27 results. No financial figures are disclosed in this advance intimation.
Trade Wings Board Meeting Date
Trade Wings Ltd has scheduled a board meeting on 13 November 2026 to consider Q2 FY27 unaudited financial results. No decisions have been made yet.
Multibase India Board Meeting Date
Multibase India intimated that its Board meeting is scheduled for 04 Nov 2026 to consider un-audited financial results for Q1/H1 FY27. No monetary figures or material decisions are announced.
AUDROC Board Meeting Date
Audroc Ltd intimated a Board meeting on November 3, 2026, to approve Q2 and H1 unaudited financial results. The trading window for designated persons is closed.
Max heights Infrastucture Board Meeting Date
Max Heights Infrastructure has intimated a board meeting on 5 November 2026 to approve unaudited financial results for Q1 and H1 FY27. No results or figures are disclosed in this advance notice.